These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26674213)

  • 21. Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.
    De Fruyt J; Deschepper E; Audenaert K; Constant E; Floris M; Pitchot W; Sienaert P; Souery D; Claes S
    J Psychopharmacol; 2012 May; 26(5):603-17. PubMed ID: 21940761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
    Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Double-Blind and Placebo-Controlled Trial of Aripiprazole in Symptomatic Youths at Genetic High Risk for Bipolar Disorder.
    Findling RL; Youngstrom EA; Rowles BM; Deyling E; Lingler J; Stansbrey RJ; McVoy M; Lytle S; Calabrese JR; McNamara NK
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):864-874. PubMed ID: 28759262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.
    Takekita Y; Fabbri C; Kato M; Nonen S; Sakai S; Sunada N; Koshikawa Y; Wakeno M; Okugawa G; Kinoshita T; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):579-88. PubMed ID: 26016467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?
    Bai Y; Chen G; Yang H; Gao K
    J Affect Disord; 2020 Jan; 261():259-270. PubMed ID: 31669925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.
    Arbaizar B; Dierssen-Sotos T; Gómez-Acebo I; Llorca J
    Gen Hosp Psychiatry; 2009; 31(5):478-83. PubMed ID: 19703642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
    Perlis RH
    Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
    Derry S; Moore RA
    BMC Psychiatry; 2007 Aug; 7():40. PubMed ID: 17705840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis.
    Zheng W; Li XB; Xiang YQ; Zhong BL; Chiu HF; Ungvari GS; Ng CH; Lok GK; Xiang YT
    Hum Psychopharmacol; 2016 Jan; 31(1):11-8. PubMed ID: 26310194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium.
    Ketter TA; Miller S; Dell'Osso B; Wang PW
    J Affect Disord; 2016 Feb; 191():256-73. PubMed ID: 26688495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
    J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Developments in the Use of Atypical Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized Controlled Trials.
    Keramatian K; Chakrabarty T; Saraf G; Yatham LN
    Curr Psychiatry Rep; 2021 May; 23(7):39. PubMed ID: 33963957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.